A new day
A fresh start
Driven to end the opioid overdose epidemic
Mission:
To end the opioid overdose and addiction epidemic and offer hope to individuals, families, and communities devastated by this crisis.
CounterX Therapeutics is at the forefront of the battle against the opioid epidemic, exploiting cutting-edge biotechnology to develop life-saving therapeutics and vaccines.
Platform:
Our proprietary xFactor® discovery platform is focused on developing novel antibody therapeutics and vaccines to address opioid dependence. By leveraging immunology, advanced bioengineering and artificial intelligence, we create targeted solutions to block the euphoric effects of opioids.
